The data to be presented show that Geminii's bioelectronic therapy slowed tumor growth, extended survival, and enhanced the activity of chemoradiation in multiple preclinical NSCLC models without ...
An innovative gene-editing strategy could establish a new way for the body to manufacture therapeutic proteins—including ...
New study reveals metabolic remodeling as an early event in diastolic dysfunction Restrictive cardiomyopathy (RCM) caused by ...
Early Career and Entrepreneurial Growth Jordan’s success did not start with rich parents, a trust fund, or an extensive ...
In today's manufacturing environments, upgrading a robot fleet often means starting from scratch—not only replacing hardware, ...
Endogenous Retroviruses (ERVs), relics from ancient viral infections, form a significant part of vertebrate genomes, including humans, where they constitute ...
Being able to rapidly reprogram Angry Kitten pods remotely based on the real-time threat environment would be hugely valuable ...
Scientists have discovered a way to supercharge the immune system’s T cells by blocking a protein called Ant2, forcing the cells to rewire how they generate energy. This shift makes them more powerful ...
Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard's lead asset AT-108 into Phase 1 clinical development -- AT-108 is a transformative immunotherapy that ...
From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...
A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results